MINI FUTURE LONG - ELANCO ANIMAL HEALTH Share Price

Certificat

DE000ME42UA2

Real-time Bid/Ask 16:24:46 10/06/2024 BST
0.79 EUR / 0.8 EUR +1.92% Intraday chart for MINI FUTURE LONG - ELANCO ANIMAL HEALTH
Current month+5.41%
1 month+110.81%
Date Price Change
10/06/24 0.78 0.00%
07/06/24 0.78 -1.27%
06/06/24 0.79 -3.66%
05/06/24 0.82 +5.13%
04/06/24 0.78 +5.41%

Delayed Quote Börse Stuttgart

Last update June 10, 2024 at 02:02 pm

More quotes

Static data

Product typeCertificat Turbo Stop Loss
Buy / SellCALL
Underlying ELANCO ANIMAL HEALTH INCORPORATED
Issuer Morgan Stanley
WKN ME42UA
ISINDE000ME42UA2
Date issued 22/11/2023
Strike 9.691 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.25
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.82
Lowest since issue 0.23
Spread 0.01
Spread %1.27%

Company Profile

Elanco Animal Health Incorporated is an animal health company. The Company is focused in delivering products and services to prevent and treat disease in farm animals and pets. Its portfolio serves animals across its core species consisting of dogs, cats and cattle, poultry, swine, sheep and aqua. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, poultry, and aquaculture. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.
Sector
-
More about the company

Ratings for Elanco Animal Health Incorporated

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Elanco Animal Health Incorporated

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
18.21 USD
Average target price
19.11 USD
Spread / Average Target
+4.97%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW